See All Slides -

Slides

Presentation TCT 2016

ELM Professional Development Presentation and Discussion

Presenter: Ehrin Armstrong

October 31, 2016

Presentation TCT 2016

ELM Professional Development Presentation and Discussion

Presenter: Saif Anwaruddin

October 31, 2016

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

FFR, iFR and Microvascular Assessment

Presenter: Verghese Mathew, Arnold Seto

October 31, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, John D. Carroll

October 30, 2016

Presentation TCT 2016

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman

October 30, 2016

Advertisement

Slides

ELM Professional Development Presentation and Discussion

ELM Professional Development Presentation and Discussion

Severe AS and LV Dysfunction

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

FFR, iFR and Microvascular Assessment

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content